---
document_datetime: 2025-05-06 15:28:31
document_pages: 10
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/xydalba-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: xydalba-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 7.1594177
conversion_datetime: 2025-12-29 21:25:41.576508
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Xydalba

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                                                                | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                 |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------|
| II/0050              | Extension of indication to include the treatment of acute bacterial skin and skin structure infections (ABSSSI) in paediatric patients from birth for Xydalba, based on final results from study DUR001- 306, together with data from three Phase 1 PK studies (A8841004, DUR001-106, and DUR001-107 | 27/03/2025                          | 02/05/2025                                  | SmPC, Labelling and PL           | Please refer to Scientific Discussion 'Xydalba- EMEA/H/C/002840/II/0050 |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | (DAL-PK-02); DUR001-306 was a Phase 3, multicenter, open-label, randomised, comparator controlled trial evaluating the safety and efficacy of a single dose of IV dalbavancin and a 2-dose regimen of once weekly IV dalbavancin (for a total of 14 days of coverage) for the treatment of ABSSSI known or suspected to be due to susceptible Gram-positive organisms in children. As a consequence, sections 4.1, 4.2, 4.4, 4.8, 5.1, 5.2 and 6.6 of the SmPC are updated. The Package Leaflet is updated in accordance. Version 8.1 of the RMP is approved with this variation. In addition, the Marketing authorisation holder (MAH) took the opportunity to introduce minor editorial changes to the PI, update the list of local representatives in the Package Leaflet in line with the latest QRD template version 10.4, and replace the MIC breakpoints table in section 5.1 of the SmPC with the agreed reference to the EMA website, in line with EMA's Guideline on the evaluation of medicinal products indicated for treatment of bacterial infections. C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or   |            |            |              |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------|
| IB/0052   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 19/12/2024 | n/a        |              |
| IAIN/0051 | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 20/09/2024 | 02/05/2025 | Annex II and |

<div style=\"page-break-after: always\"></div>

|                     | responsible for batch release                                                                                                                                                                                                                |            |            | PL                     |                                                                         |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------|
| PSUSA/10350 /202311 | Periodic Safety Update EU Single assessment - dalbavancin                                                                                                                                                                                    | 11/07/2024 | n/a        |                        | PRAC Recommendation - maintenance                                       |
| N/0049              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                             | 05/04/2024 | 02/05/2025 | PL                     |                                                                         |
| IA/0048             | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 06/03/2024 | n/a        |                        |                                                                         |
| II/0043             | C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one                                                                                                               | 13/10/2022 | 09/12/2022 | SmPC and PL            | Please refer to the Scientific Discussion 'Xydalba-H-C- 002840-II-0043' |
| IA/0046             | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                         | 24/06/2022 | n/a        |                        |                                                                         |
| T/0045              | Transfer of Marketing Authorisation                                                                                                                                                                                                          | 29/04/2022 | 13/06/2022 | SmPC, Labelling and PL |                                                                         |
| IA/0044/G           | This was an application for a group of variations. B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process A.4 - Administrative change - Change in the name     | 04/02/2022 | n/a        |                        |                                                                         |

<div style=\"page-break-after: always\"></div>

|                     | and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                                                                  |            |            |                 |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------------------------|
| N/0042              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                             | 11/10/2021 | 13/06/2022 | PL              |                                   |
| PSUSA/10350 /202011 | Periodic Safety Update EU Single assessment - dalbavancin                                                                                                                                                                                                                                                                                                                                    | 10/06/2021 | n/a        |                 | PRAC Recommendation - maintenance |
| IA/0041             | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                | 03/03/2021 | n/a        |                 |                                   |
| IAIN/0039/G         | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 25/01/2021 | 19/10/2021 | Annex II and PL |                                   |
| II/0037             | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                                                                | 14/01/2021 | n/a        |                 |                                   |
| IB/0038             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                               | 26/10/2020 | 19/10/2021 | SmPC and PL     |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0035/G           | This was an application for a group of variations. B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation                                                                                                                                                                                                                                                                        | 23/10/2020   | n/a   |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| IA/0036/G           | This was an application for a group of variations. B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material | 02/10/2020   | n/a   |                                   |
| PSUSA/10350 /201911 | Periodic Safety Update EU Single assessment - dalbavancin                                                                                                                                                                                                                                                                                                                                                                                                                           | 11/06/2020   | n/a   | PRAC Recommendation - maintenance |
| IA/0034             | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                          | 20/05/2020   | n/a   |                                   |
| IA/0033             | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                          | 20/05/2020   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

| N/0030              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                  | 18/02/2020   | 19/10/2021   | PL                               |                                                                                                                                                                                                                                                                       |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0031             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                     | 17/02/2020   | n/a          |                                  |                                                                                                                                                                                                                                                                       |
| R/0028              | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                           | 19/09/2019   | 05/12/2019   | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Xydalba in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IA/0029             | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                        | 13/11/2019   | n/a          |                                  |                                                                                                                                                                                                                                                                       |
| PSUSA/10350 /201811 | Periodic Safety Update EU Single assessment - dalbavancin                                                                                                                                                                                                                                                                                                                         | 14/06/2019   | n/a          |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                     |
| IAIN/0027/G         | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.c.2 - Change to importer, batch release | 12/03/2019   | 31/07/2019   | Annex II and PL                  |                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|                     | Including batch control/testing                                                                                                                                                                                                                                                                                                                                      |            |            |                                  |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| IB/0025             | B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                                                                                                                                                                                                  | 17/12/2018 | n/a        |                                  |                                   |
| IB/0024             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                       | 14/12/2018 | 31/07/2019 | SmPC and PL                      |                                   |
| IAIN/0023/G         | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 01/08/2018 | 31/07/2019 | SmPC, Annex II, Labelling and PL |                                   |
| PSUSA/10350 /201711 | Periodic Safety Update EU Single assessment - dalbavancin                                                                                                                                                                                                                                                                                                            | 14/06/2018 | n/a        |                                  | PRAC Recommendation - maintenance |
| IA/0020             | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                           | 18/01/2018 | n/a        |                                  |                                   |
| PSUSA/10350 /201705 | Periodic Safety Update EU Single assessment - dalbavancin                                                                                                                                                                                                                                                                                                            | 30/11/2017 | n/a        |                                  | PRAC Recommendation - maintenance |
| IB/0018/G           | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a                                                                                                                                                                                                                                                              | 08/11/2017 | n/a        |                                  |                                   |

<div style=\"page-break-after: always\"></div>

|                     | starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place   |            |            |                        |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| IA/0019             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 27/09/2017 | n/a        |                        |                                   |
| PSUSA/10350 /201611 | Periodic Safety Update EU Single assessment - dalbavancin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 09/06/2017 | n/a        |                        | PRAC Recommendation - maintenance |
| N/0016              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 17/03/2017 | 31/07/2019 | PL                     |                                   |
| T/0014              | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 16/12/2016 | 27/01/2017 | SmPC, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0013             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                | 01/12/2016   | 27/01/2017   | SmPC   |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------|-----------------------------------|
| PSUSA/10350 /201605 | Periodic Safety Update EU Single assessment - dalbavancin                                                                                                                                                                                                                                                                                | 01/12/2016   | n/a          |        | PRAC Recommendation - maintenance |
| IB/0011             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                            | 31/08/2016   | n/a          |        |                                   |
| IA/0010             | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                      | 11/07/2016   | n/a          |        |                                   |
| N/0009              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                         | 22/06/2016   | 27/01/2017   | PL     |                                   |
| PSUSA/10350 /201511 | Periodic Safety Update EU Single assessment - dalbavancin                                                                                                                                                                                                                                                                                | 09/06/2016   | n/a          |        | PRAC Recommendation - maintenance |
| IA/0007/G           | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits | 25/04/2016   | n/a          |        |                                   |

<div style=\"page-break-after: always\"></div>

| N/0008              | Update of the package leaflet with revised contact details of the local representatives for Hungary and Slovenia. The MAH also took the opportunity to make corrections to some of the local representatives contact details in the Spanish, Greek, Croatian, Hungarian, Icelandic, Lithuanian, Slovakian and Slovenian package leaflets in line with the English texts. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   | 22/04/2016   | 27/01/2017   | PL          |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------|-----------------------------------|
| II/0004             | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                           | 28/01/2016   | 02/03/2016   | SmPC and PL |                                   |
| PSUSA/10350 /201505 | Periodic Safety Update EU Single assessment - dalbavancin                                                                                                                                                                                                                                                                                                                                                                                                                   | 03/12/2015   | n/a          |             | PRAC Recommendation - maintenance |
| II/0003             | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                                                                                                                                               | 24/09/2015   | n/a          |             |                                   |
| IAIN/0001           | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                             | 28/04/2015   | n/a          |             |                                   |
| N/0002              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                            | 17/04/2015   | 02/03/2016   | PL          |                                   |